| Honokiol: A non-adipogenic PPARγ agonist from nature AG Atanasov, JN Wang, SP Gu, J Bu, MP Kramer, L Baumgartner, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (10), 4813-4819, 2013 | 152 | 2013 |
| CD74 is a novel transcription regulator N Gil-Yarom, L Radomir, L Sever, MP Kramer, H Lewinsky, C Bornstein, ... Proceedings of the National Academy of Sciences 114 (3), 562-567, 2017 | 130 | 2017 |
| CCR2 Regulates the Immune Response by Modulating the Interconversion and Function of Effector and Regulatory T Cells E Bakos, CA Thaiss, MP Kramer, S Cohen, L Radomir, I Orr, ... The Journal of Immunology 198 (12), 4659-4671, 2017 | 84 | 2017 |
| Golgi organization is regulated by proteasomal degradation A Eisenberg-Lerner, R Benyair, N Hizkiahou, N Nudel, R Maor, ... Nature communications 11 (1), 409, 2020 | 77 | 2020 |
| Polyacetylenes from Notopterygium incisum–new selective partial agonists of peroxisome proliferator-activated receptor-gamma AG Atanasov, M Blunder, N Fakhrudin, X Liu, SM Noha, C Malainer, ... PLoS One 8 (4), e61755, 2013 | 77 | 2013 |
| CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia H Lewinsky, AF Barak, V Huber, MP Kramer, L Radomir, L Sever, I Orr, ... The Journal of clinical investigation 128 (12), 5465-5478, 2018 | 54 | 2018 |
| Pro-inflammatory cytokines alter the immunopeptidome landscape by modulation of HLA-B expression A Javitt, E Barnea, M Kramer, H Wolf-Levy, Y Levin, A Admon, Y Merbl Frontiers in immunology 10, 141, 2019 | 51 | 2019 |
| Roscovitine up‐regulates p53 protein and induces apoptosis in human HeLaS3 cervix carcinoma cells J Węsierska‐Gądek, S Wandl, MP Kramer, C Pickem, V Kryštof, SB Hajek Journal of cellular biochemistry 105 (5), 1161-1171, 2008 | 47 | 2008 |
| Revealing the cellular degradome by mass spectrometry analysis of proteasome-cleaved peptides H Wolf-Levy, A Javitt, A Eisenberg-Lerner, A Kacen, A Ulman, D Sheban, ... Nature biotechnology 36 (11), 1110-1116, 2018 | 41 | 2018 |
| Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells J Węsierska-Gądek, MP Kramer, M Maurer Food and chemical toxicology 46 (4), 1327-1333, 2008 | 36 | 2008 |
| T Cells Regulate Peripheral Naive Mature B Cell Survival by Cell–Cell Contact Mediated through SLAMF6 and SAP L Radomir, S Cohen, MP Kramer, E Bakos, H Lewinsky, A Barak, Z Porat, ... The Journal of Immunology 199 (8), 2745-2757, 2017 | 26 | 2017 |
| Glycolytic switch in response to betulinic acid in non-cancer cells EH Heiss, MP Kramer, AG Atanasov, H Beres, D Schachner, VM Dirsch PLoS One 9 (12), e115683, 2014 | 25 | 2014 |
| Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence G Schmid, MP Kramer, M Maurer, S Wandl, J Węsierska‐Gądek Journal of cellular biochemistry 101 (6), 1355-1369, 2007 | 25 | 2007 |
| CD84 mediates CLL-microenvironment interactions A Marom, AF Barak, MP Kramer, H Lewinsky, I Binsky-Ehrenreich, ... Oncogene 36 (5), 628-638, 2017 | 24 | 2017 |
| Monitoring of Long‐Term Effects of Resveratrol on Cell Cycle Progression of Human HeLa Cells after Administration of a Single Dose MP Kramer, J Węsierska‐Gądek Annals of the New York Academy of Sciences 1171 (1), 257-263, 2009 | 23 | 2009 |
| The impact of multi-targeted cyclin-dependent kinase inhibition in breast cancer cells: clinical implications J Wesierska-Gadek, MP Kramer Expert Opinion on Investigational Drugs 20 (12), 1611-1628, 2011 | 22 | 2011 |
| CD74 is a regulator of hematopoietic stem cell maintenance S Becker-Herman, M Rozenberg, C Hillel-Karniel, N Gil-Yarom, ... PLoS Biology 19 (3), e3001121, 2021 | 19 | 2021 |
| A new, unexpected action of olomoucine, a CDK inhibitor, on normal human cells: Up‐regulation of CLIMP‐63, a cytoskeleton‐linking membrane protein J Węsierska‐Gądek, M Gueorguieva, MP Kramer, C Ranftler, B Sarg, ... Journal of cellular biochemistry 102 (6), 1405-1419, 2007 | 15 | 2007 |
| The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia J Wakim, E Arman, S Becker-Herman, MP Kramer, E Bakos, I Shachar, ... Oncogene 36 (26), 3686-3694, 2017 | 12 | 2017 |
| Signaling of DNA damage is not sufficient to induce p53 response:(re) activation of wt p53 protein strongly depends on cellular context J Węsierska‐Gądek, M Gueorguieva, O Komina, G Schmid, MP Kramer Journal of cellular biochemistry 103 (5), 1607-1620, 2008 | 10 | 2008 |
